Chemleader Biomedical-Small Molecules 丨Intermediates 丨Drug Impurities

(2S,3R,4S,5S,6R)-2-(((2S,3R,4S,5S,6R)-4,5-二羟基-2-(((3R,6R)-2-羟基-6-((3S,8S,9R,10R,11R,13R,14S,17R)-11-羟基-4,4,9,13,14-五甲基-3-(((2R,3R,4S,5S,6R)-3,4,5-三羟基-6-((((2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)甲基)四氢-2H-吡喃-2-基)氧基)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊[a]菲-17-基)-2-甲基庚-3-基)氧基)-6-((((2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-yl)氧基)甲基)四氢-2H-吡喃-3-基)氧基)-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇; 罗汉果苷V; 罗汉果甜苷V; 罗汉果皂苷V

Mogroside V

ChemLeader 98+%

产品编号：HL1227

CAS No.：88901-36-4

MDLNo：MFCD00238649

分子式：C60H102O29

分子量：1,287.43

下载MSDS

选择规格

选择数量

- +

发送询价加入购物车

基本信息

中文名称	(2S,3R,4S,5S,6R)-2-(((2S,3R,4S,5S,6R)-4,5-二羟基-2-(((3R,6R)-2-羟基-6-((3S,8S,9R,10R,11R,13R,14S,17R)-11-羟基-4,4,9,13,14-五甲基-3-(((2R,3R,4S,5S,6R)-3,4,5-三羟基-6-((((2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)甲基)四氢-2H-吡喃-2-基)氧基)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-十四氢-1H-环戊[a]菲-17-基)-2-甲基庚-3-基)氧基)-6-((((2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-yl)氧基)甲基)四氢-2H-吡喃-3-基)氧基)-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇; 罗汉果苷V; 罗汉果甜苷V; 罗汉果皂苷V
英文名称	Mogroside V
CAS号	88901-36-4
分子式	C60H102O29
分子量	1,287.43
MDL	MFCD00238649
外观	White to off-white powder
储存条件	4°C, protect from light

安全信息

产品详情

Mogroside V, a key active component in Siraitiae Fructus, is a potent non-sugar sweetener with an in vitro AMPK-activating effect. It demonstrates anti-inflammatory properties in murine macrophages and a murine ear edema model, and it may protect against LPS-induced airway inflammation in acute lung injury (ALI) models. This triterpenoid glycoside also possesses antioxidant capabilities, mitigates intracellular reactive oxygen species (ROS) levels, and enhances mitochondrial function. Mogroside V exhibits anti-oxidative, anti-diabetic, and anti-carcinogenic effects, making it a valuable compound for diabetes research. It is particularly relevant for pancreatic cancer models, where it inhibits tumor growth.